[go: up one dir, main page]

UY32538A - Tapones lagrimales - Google Patents

Tapones lagrimales

Info

Publication number
UY32538A
UY32538A UY0001032538A UY32538A UY32538A UY 32538 A UY32538 A UY 32538A UY 0001032538 A UY0001032538 A UY 0001032538A UY 32538 A UY32538 A UY 32538A UY 32538 A UY32538 A UY 32538A
Authority
UY
Uruguay
Prior art keywords
tear
tear plugs
plugs
caps
anchor
Prior art date
Application number
UY0001032538A
Other languages
English (en)
Inventor
Lust Victor
Sr Phillip King Parnell
Vincent G Mcateer
Schwam Brian
Chaouk Hasson
Original Assignee
Johnson & Johnson Vision Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Prod filed Critical Johnson & Johnson Vision Prod
Publication of UY32538A publication Critical patent/UY32538A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

Se describen tapones lagrimales adecuados para suministrar agentes terapéuticos; los tapones tienen un cuerpo, una porción en la cual se carga el agente terapéutico. Un bobinado alrededor del cuerpo, y una alargada o de anclaje en un extremo.
UY0001032538A 2009-03-31 2010-04-05 Tapones lagrimales UY32538A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16541709P 2009-03-31 2009-03-31

Publications (1)

Publication Number Publication Date
UY32538A true UY32538A (es) 2010-09-30

Family

ID=42320849

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032538A UY32538A (es) 2009-03-31 2010-04-05 Tapones lagrimales

Country Status (14)

Country Link
US (1) US20100256578A1 (es)
EP (1) EP2413853A1 (es)
JP (1) JP2012521858A (es)
KR (1) KR20120013346A (es)
CN (1) CN102448412A (es)
AR (1) AR077739A1 (es)
AU (1) AU2010234879A1 (es)
BR (1) BRPI1014062A2 (es)
CA (1) CA2758054A1 (es)
RU (1) RU2011143792A (es)
SG (2) SG10201401086VA (es)
TW (1) TWI495459B (es)
UY (1) UY32538A (es)
WO (1) WO2010117722A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US9421127B2 (en) * 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
AU2010249683B2 (en) 2009-05-18 2015-06-25 Glaukos Corporation Drug eluting ocular implant
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259352B2 (en) * 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
EP2654715B1 (en) 2010-11-24 2017-01-25 Dose Medical Corporation Drug eluting ocular implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
CA2950187A1 (en) 2014-05-29 2015-12-03 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
CN104398328A (zh) * 2014-09-30 2015-03-11 浦易（上海）生物技术有限公司 一种可完全降解的载药的鼻泪管支架及其植入系统
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN105879126A (zh) * 2016-03-24 2016-08-24 杭州亚慧生物科技有限公司 一种超润滑血清白蛋白泪点塞及其制备方法
EP3442479A1 (en) 2016-04-20 2019-02-20 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
CN106491270B (zh) * 2016-12-23 2018-08-14 中国医科大学附属第一医院 一种泪点扩张装置
CN110711075A (zh) * 2018-07-11 2020-01-21 吴坚 一种泪小管栓塞
CA3209420A1 (en) 2021-02-24 2022-09-01 Peter Jarrett Intracanalicular depot inserter device

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906551A (en) * 1974-02-08 1975-09-23 Klaas Otter Artificial intra-ocular lens system
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US4915684A (en) * 1988-06-21 1990-04-10 Mackeen Donald L Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
US4959048A (en) * 1989-01-17 1990-09-25 Helix Medical, Inc. Lacrimal duct occluder
US5334137A (en) * 1992-02-21 1994-08-02 Eagle Vision, Inc. Lacrimal fluid control device
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US6149684A (en) * 1995-06-07 2000-11-21 Herrick; Robert S. Punctum plug having a thin elongated lip and a distal starting tip and method of using
US6254562B1 (en) * 1997-02-04 2001-07-03 Alain Fouere Meatus plug for lachrymal canal capable of being screwed
US6082362A (en) * 1997-03-27 2000-07-04 Eagle Vision, Inc. Punctum plug
US6041785A (en) * 1997-03-27 2000-03-28 Eaglevision, Inc. Punctum plug
US6367929B1 (en) * 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US5962548A (en) * 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6822016B2 (en) * 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6099852A (en) * 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US6629533B1 (en) * 2000-06-30 2003-10-07 Eagle Vision, Inc. Punctum plug with at least one anchoring arm
FR2829019B3 (fr) * 2001-08-31 2003-10-31 Alain Fouere Bouchons lacrymaux et methodes de mise en place de ces dispositifs
US7204253B2 (en) * 2003-05-22 2007-04-17 Clarity Corporation Punctum plug
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
WO2006014434A2 (en) * 2004-07-02 2006-02-09 Eliot Lazar Treatment medium delivery device and methods for delivery
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US20060276738A1 (en) * 2005-06-06 2006-12-07 Becker Bruce B Lacrimal drainage bypass device and method
US8088161B2 (en) * 2005-07-28 2012-01-03 Visioncare Ophthalmic Technologies Inc. Compressed haptics
KR101062796B1 (ko) * 2006-03-31 2011-09-06 큐엘티 인코포레이티드 약물 요법을 위한 비루관 배출계 임플란트
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
CN101505696B (zh) * 2006-06-21 2012-11-14 庄臣及庄臣视力保护公司 用于递送活性试剂的泪点塞
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
CN101616640B (zh) * 2006-12-26 2013-02-27 Qlt插入传输公司 用于抑制视觉缺陷的给药植入体
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
CN101984745B (zh) * 2007-09-07 2013-08-14 Qlt股份有限公司 用于持续释放治疗药物的药物核心
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
AU2010206610A1 (en) * 2009-01-23 2011-08-11 Qlt Inc. Sustained released delivery of one or more agents
US8911495B2 (en) * 2009-03-16 2014-12-16 Endoshape, Inc. Reliably retained shape memory ophthalmological implants

Also Published As

Publication number Publication date
TW201039805A (en) 2010-11-16
AR077739A1 (es) 2011-09-21
BRPI1014062A2 (pt) 2016-04-12
SG174972A1 (en) 2011-11-28
SG10201401086VA (en) 2014-10-30
CA2758054A1 (en) 2010-10-14
RU2011143792A (ru) 2013-05-10
AU2010234879A1 (en) 2011-10-27
WO2010117722A1 (en) 2010-10-14
EP2413853A1 (en) 2012-02-08
US20100256578A1 (en) 2010-10-07
TWI495459B (zh) 2015-08-11
JP2012521858A (ja) 2012-09-20
CN102448412A (zh) 2012-05-09
KR20120013346A (ko) 2012-02-14

Similar Documents

Publication Publication Date Title
UY32538A (es) Tapones lagrimales
UY32537A (es) Tapones lagrimales
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
CL2016002372A1 (es) Cenicriviroc para el tratamiento de la fibrosis.
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
CL2011001811A1 (es) Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico.
CL2015003135A1 (es) Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimorficas y métodos de uso.
CL2014001002A1 (es) Perno de anclaje en roca que incluye un cuerpo cilindrico alargado que tiene, un primer extremo distal y un segundo extremo proximal opuesto, una porcion roscada en el segundo extremo, un primer anclaje situado en o al menos parcialmente situado en una primera porcion de extremo del cuerpo, un segundo anclaje, una primera porcion de vastago entre el primer y el segundo anclaje.
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
MX382405B (es) Método para suministrar un agente activo.
IL254813A0 (en) Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof
PT3216448T (pt) Composições veterinárias orais parasiticidas que compreendem agentes, métodos e métodos ativos que agem sistemicamente
CO6680694A2 (es) Composición y método para la reparación y regeneración muscular
AR084677A1 (es) Tapones lagrimales para la liberacion controlada de agentes terapeuticos
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
BR112013010102A2 (pt) microagulha, arranjo de microagulhas, dispositivo de microagulhas, e, método para administrar um agente medicinal
AR105205A1 (es) Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
MX2017003638A (es) Microparticulas inyectables para liberacion hiper-localizada de agentes terapeuticos.
CL2014003332A1 (es) Una composicion que comprende un plaguicida solido insoluble en agua, un plaguicida soluble en agua, un agente reologico y un agente humectante-dispersante.
PE20161158A1 (es) Aparato y metodo de apoyo en tierra
CL2013002905A1 (es) Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares.
CL2014001468A1 (es) Un componente de cable que comprende, un cuerpo principal donde al menos una parte esta hecho de un material de aislacion, al menos una porcion no inflamable dispuesta en el material de aislacion formando al menos un 25% en volumen de dicho componente; y un cable.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201020